文献速递血栓与止血

COVID-19住院后90天随访中有症状且影像证实的静脉血栓栓塞发生率

Incidence of symptomatic, image-confirmed venous thromboembolism following hospitalization for COVID-19 with 90-day follow-up.
PubMed 文献 · Blood Adv · 2020-01-01

该回顾性观察研究纳入303例因COVID-19住院至少24小时的连续成人患者,排除入院时即有VTE者,随访至入院后90天。结果显示住院期间有症状影像证实VTE发生率为5.9%,90天为7.2%,需高级别护理者达23.9%;住院期间出血4.3%,大出血1.3%。出院时无抗凝指征的152例中97%未接受出院后预防,42天VTE发生率为2.6%。

要点

  • COVID-19住院患者90天有症状影像证实VTE发生率为7.2%,需高级别护理者达23.9%。
  • 住院期间出血发生率为4.3%,大出血1.3%,多数出血发生在普通病房。
  • 出院时无抗凝指征者97%未接受出院后预防,42天VTE发生率为2.6%。

核心结论

  • COVID-19住院后90天内有症状影像证实VTE发生率为7.2%,需高级别护理者更高达23.9%。
  • 住院期间出血发生率为4.3%,提示强化标准血栓预防策略需谨慎。
  • 出院时无抗凝指征者42天VTE发生率为2.6%,支持开展出院后延长血栓预防的大型前瞻性随机对照试验。

研究设计与样本

  • 回顾性观察研究,纳入303例因COVID-19住院至少24小时的连续成人患者,排除入院时即有VTE者。
  • 通过病历和国家VTE网络收集数据,随访至入院后90天或确认死亡。
  • 78%患者最高护理级别为普通病房,22%需更高依赖护理(12%无创通气,10%有创通气)。

主要发现

  • 住院期间有症状影像证实VTE发生率为5.9%,入院后90天为7.2%,需更高依赖护理者90天为23.9%。
  • 一半VTE事件为肺影像上孤立的段或亚段缺损。
  • 住院期间出血13例(4.3%),其中大出血1.3%;多数出血发生在普通病房,6例正在接受治疗剂量抗凝。
  • 出院时无抗凝指征的152例中,97%未接受出院后血栓预防,3%接受7天低分子肝素治疗;该组出院后42天有症状VTE发生率为2.6%。

关键数值与推荐

  • 97.0%患者接受标准血栓预防或已在接受治疗剂量抗凝(17.5%)。
  • 住院期间有症状影像证实VTE发生率5.9%,90天7.2%,需更高依赖护理者90天23.9%。
  • 住院期间出血发生率4.3%,大出血1.3%。
  • 出院时无抗凝指征者出院后42天有症状VTE发生率2.6%。

临床怎么用

  • COVID-19住院患者应评估VTE风险并考虑标准血栓预防,但需警惕出血风险,尤其普通病房患者。
  • 需更高依赖护理的COVID-19患者VTE风险显著升高,应加强监测。
  • 出院时无抗凝指征者出院后VTE风险仍存在,是否延长预防需个体化并等待随机对照试验证据。

局限性

  • 回顾性观察设计,可能存在未测量混杂和事件漏报。
  • 单中心数据,样本量303例,外推性有限。
  • 出院后预防策略非随机分配,无法推断因果。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Although COVID-19 has been reported to be associated with high rates of venous thromboembolism (VTE), the risk of VTE and bleeding after hospitalization for COVID-19 remains unclear, and the optimal hospital VTE prevention strategy is not known. We collected retrospective observational data on thrombosis and bleeding in 303 consecutive adult patients admitted to the hospital for at least 24 hours for COVID-19. Patients presenting with VTE on admission were excluded. Data were collected until 90 days after admission or known death by using medical records and an established national VTE network. Maximal level of care was ward based in 78% of patients, with 22% requiring higher dependency care (12% noninvasive ventilation, 10% invasive ventilation). Almost all patients (97.0%) received standard thromboprophylaxis or were already receiving therapeutic anticoagulation (17.5%). Symptomatic image-confirmed VTE occurred in 5.9% of patients during index hospitalization, and in 7.2% at 90 days after admission (23.9% in patients requiring higher dependency care); half the events were isolated segmental or subsegmental defects on lung imaging. Bleeding occurred in 13 patients (4.3%) during index hospitalization (1.3% had major bleeding). The majority of bleeds occurred in patients on the general ward, and 6 patients were receiving treatment-dose anticoagulation, highlighting the need for caution in intensifying standard thromboprophylaxis strategies. Of 152 patients discharged from the hospital without an indication for anticoagulation, 97% did not receive thromboprophylaxis after discharge, and 3% received 7 days of treatment with low molecular weight heparin after discharge. The rate of symptomatic VTE in this group at 42 days after discharge was 2.6%, highlighting the need for large prospective randomized controlled trials of extended thromboprophylaxis after discharge in COVID-19.

来源:Blood Adv,查看原文。版权归原作者所有。

引用

  1. Salisbury R, Iotchkova V, Jaafar S, et al. Incidence of symptomatic, image-confirmed venous thromboembolism following hospitalization for COVID-19 with 90-day follow-up. Blood Adv. 2020. PMID: 33351117. doi:10.1182/bloodadvances.2020003349

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。